Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin effect on heart rate variability in diabetic painful peripheral neuropathy
IRCT201212019014N14Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gabapentin in peripheral neuropathy, diabetic neuropathy and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Heart rate variability parameters. Started Dec 2012; status: completed.
02
Drugs
gabapentin
03
Conditions
peripheral neuropathydiabetic neuropathytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201212019014N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212019014N14.